Atlas Venture Fund XII, L.P.
Known title: 10% OwnerCIK: 0001812049
Associated companies
Transaction History
| JBIO | ▼ Sell | Other | 310,388 | $0 | 7/15/2022 | View on chart |
| JBIO | ▼ Sell | Other | 465,582 | $0 | 4/1/2022 | View on chart |
| JBIO | ▼ Sell | Other | 310,388 | $0 | 7/15/2022 | View on chart |
| JBIO | ▼ Sell | Other | 465,582 | $0 | 4/1/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Jade Biosciences Schedules Conference Participation
Jade Biosciences has announced its participation in upcoming industry conferences. Such events typically provide opportunities for company leadership to engage with institutional investors and discuss business developments. The stock currently trades within its 52-week range, with analysts maintaining price targets significantly above current levels.
Jade Biosciences Schedules Conference Participation. Jade Biosciences has announced its participation in upcoming industry conferences. Such events typically provide opportunities for company leadership to engage with institutional investors and discuss business developments. The stock currently trades within its 52-week range, with analysts maintaining price targets significantly above current levels.